Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and <i>In Vitro</i> Characterization

<div>TEM images: (a) SLN/Dox; (b) SLn/Dox/Dexa. The images indicate the formation of spherical-shaped nanoparticles.</div>

BioMed Research International

fig6

Figure 6

Figure 6: Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and <i>In Vitro</i> Characterization 

Figure 6 | Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and In Vitro Characterization 